» Articles » PMID: 17495767

Immunohistochemical Demonstration of Advanced Glycation End Products and the Effects of Advanced Glycation End Products in Ossified Ligament Tissues in Vitro

Overview
Specialty Orthopedics
Date 2007 May 15
PMID 17495767
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Study Design: This study correlates advanced glycation end products with ossified ligament tissues of the cervical spine in vitro.

Objective: To investigate the effect of advanced glycation end products on ossification of the spinal ligaments in vitro.

Summary Of Background Data: We have hypothesized that an accumulation of advanced glycation end products in the spinal ligament might result in some observable change in specific growth factors responsible for ossification in the spinal ligaments.

Methods: Samples of the posterior longitudinal and yellow ligaments were harvested from patients (n = 5) with ossification of the posterior longitudinal ligament, and analyzed for the presence of advanced glycation end products and their receptor advanced glycation end product receptor by immunohistochemistry. Real-time polymerase chain reaction (PCR) was used to quantify the messenger ribonucleic acid (mRNA) levels of bone morphogenetic protein (BMP)-2, BMP-7, alkaline phosphatase, an osteoblast-specific transcription factor 1 (Cbfa1), and osteocalcin from yellow ligament cells treated with advanced glycation end products.

Results: Immunohistochemical analysis revealed that advanced glycation end products and advanced glycation end product receptor were localized to within the posterior longitudinal and yellow ligaments. Advanced glycation end products were found to increase significantly the expression of BMP-2, BMP-7, Cbfa1, and osteocalcin at the mRNA levels after treatment with advanced glycation end products (1 microg/mL).

Conclusions: This is the first report to investigate the correlation, if any, between the ossified spinal ligament and advanced glycation end products. These results suggested that accumulation in advanced glycation end products and their interaction with advanced glycation end product receptor were 1 of the important risk factors in the process of ossification in the spinal ligaments.

Citing Articles

Erroneous Differentiation of Tendon Stem/Progenitor Cells in the Pathogenesis of Tendinopathy: Current Evidence and Future Perspectives.

Gao Y, Wang H, Shi L, Lu P, Dai G, Zhang M Stem Cell Rev Rep. 2024; 21(2):423-453.

PMID: 39579294 DOI: 10.1007/s12015-024-10826-z.


Evaluating the role of type 2 diabetes mellitus in rotator cuff tendinopathy: Development and analysis of a novel rat model.

Xu K, Zhang L, Ren Z, Wang T, Zhang Y, Zhao X Front Endocrinol (Lausanne). 2022; 13:1042878.

PMID: 36299460 PMC: 9588920. DOI: 10.3389/fendo.2022.1042878.


Dissatisfaction Risk Factors of Patients after Laminectomy for Thoracic Ossification of Ligamentum Flavum: A Retrospective Cohort Study of Different Follow-Up Periods.

Wang Z, Yang S, Gao X, Wang Z, Ding W, Yang D Pain Res Manag. 2021; 2021:3971396.

PMID: 34966472 PMC: 8712141. DOI: 10.1155/2021/3971396.


Advanced glycation end productions and tendon stem/progenitor cells in pathogenesis of diabetic tendinopathy.

Shi L, Lu P, Dai G, Li Y, Rui Y World J Stem Cells. 2021; 13(9):1338-1348.

PMID: 34630866 PMC: 8474716. DOI: 10.4252/wjsc.v13.i9.1338.


Biology of Tendon Stem Cells and Tendon in Aging.

Lui P, Wong C Front Genet. 2020; 10:1338.

PMID: 32010194 PMC: 6976534. DOI: 10.3389/fgene.2019.01338.